Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 136-142 , November 2006

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06

  • Bryan H. Burmeister

      Affiliations

    • University of Queensland, Melanoma Clinic, Princess Alexandra Hospital, Brisbane, Australia
    • Corresponding Author InformationCorresponding author. Bryan H. Burmeister, University of Queensland, Princess Alexandra Hospital, Woolloongabba 4102, Australia.
    • ,
  • B. Mark Smithers

      Affiliations

    • University of Queensland, Melanoma Clinic, Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • Elizabeth Burmeister

      Affiliations

    • Queensland Cancer Control Analysis Team, Brisbane, Australia
    • ,
  • Kathryn Baumann

      Affiliations

    • Radiation Oncology Mater Centre, Brisbane, Australia
    • ,
  • Sidney Davis

      Affiliations

    • William Buckland Radiotherapy Centre, Melbourne, Australia
    • ,
  • Hedley Krawitz

      Affiliations

    • Auckland Hospital, Auckland, New Zealand
    • ,
  • Carol Johnson

      Affiliations

    • Wellington Hospital, Wellington, New Zealand
    • ,
  • Nigel Spry

      Affiliations

    • Sir Charles Gairdner Hospital, Perth, Australia

Received 24 May 2006 ,Revised 25 September 2006 ,Accepted 2 October 2006.

References 

  1. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635–3648
  2. Gray RJ, Pockaj BA, Kirkwood JM. An update on adjuvant interferon for melanoma. Cancer Control. 2002;9:16–21
  3. Habermalz HJ, Fischer JJ. Radiation therapy of malignant melanoma: experience with high individual treatment doses. Cancer. 1976;38:2258–2262
  4. Miller AB, Hoogstraten B, Staquet M, et al. Reporting of results of cancer treatment. Cancer. 1981;47:207–214
  5. Burmeister BH, Smithers BM, Davis S, et al. Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity. ANZ J Surg. 2002;72:344–348
  6. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg. 1989;124:1051–1055
  7. Miller EJ, Daly JM, Synnestvedt M, et al. Loco-regional nodal relapse in melanoma. Surg Oncol. 1992;1:333–340
  8. Lee RJ, Gibbs JF, Proulx GM, et al. Nodal basin recurrence following nodal dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2000;46:467–474
  9. Creagan ET, Cupps RE, Ivins JC, et al. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma. A randomized, prospective study. Cancer. 1978;42:2206–2210
  10. O’Brien CJ, Petersen-Schaefer K, Stevens GN, et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic melanoma. Head Neck. 1997;19:589–594
  11. Stevens G, Thompson JF, Firth I, et al. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer. 2000;88:88–94
  12. Corry J, Smith JG, Bishop M, Ainslie J. Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys. 1999;44:1065–1069
  13. Ballo MT, Bonnen MD, Garden AS, et al. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer. 2003;97:1789–1796
  14. Ballo MT, Strom EA, Zagars GK, et al. Adjuvant irradiation for axillary metastases form malignant melanoma. Int J Radiat Oncol Biol Phys. 2002;52:964–972
  15. Ballo MT, Zagars GK, Gershenwald JE, et al. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ann Surg Oncol. 2004;11:1079–1084
  16. Ballo MT, Ross MI, Cormier JN, et al. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys. 2006;64:106–113
  17. Fuhrmann D, Lippold A, Borrosch F, et al. Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanoma?. Br J Dermatol. 2001;144:66–70
  18. Shen P, Wanek LA, Morton DL. Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?. Ann Surg Oncol. 2000;7:554–559
  19. Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Canner Treat Rev. 2005;31:18–26

☆ The study was conducted as a multi-centre trial under the auspices of the Trans Tasman Radiation Oncology Group (TROG).

PII: S0167-8140(06)00529-9

doi: 10.1016/j.radonc.2006.10.001

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 136-142 , November 2006

Article Tools

* Image Usage & Resolution